Pharmaceutical company in
Bern

Dr. E. Gräub AG

Since 1947 · 21–50 empl.·5.0(10)

Dr. E. Gräub AG develops, manufactures and markets health products for livestock, companion animals and horses. Its range includes its own products as well as selected third-party products.

Galenica AG

Since 2017 · 500+ empl.·3.6(38)

Galenica AG is a healthcare company that operates a network of over 20 business units and provides integrated services for pharmacies, pharmaceutical manufacturers, hospitals, nursing homes and other healthcare partners. Its activities include pharmacy retail and wholesale, logistics, pharmaceutical manufacturing, digital health and IT solutions, home-care services and consulting.

InnoMedica Schweiz AG

Since 1988 · 21–50 empl.

The core activity of InnoMedica is the development and production of nanotransport systems for the pharmaceutical industry, particularly for oncology, neurology and immunology. The company focuses on researching and developing nanocarriers that can release active ingredients in a targeted manner in the body, aiming to achieve improved efficacy with reduced side effects. Production takes place in its own GMP-certified nanofactory, which covers the entire value chain from raw material production to final product manufacturing.

Montavit AG

Since 1994 · 1–10 empl.

WALA Schweiz AG

Since 1997 · 21–50 empl.

The core activity of WALA is the development, manufacture and marketing of medicinal products and products based on medicinal plants and anthroposophic medicine.

ABJ International Inc.

Since 2000 · 1–10 empl.

ABJ International Inc. operates the Vali-Suisse division, which provides GMP validation and revalidation services for sterilizers, washer-disinfectors, pouch sealers and ultrasonic baths. Its services include testing in accordance with applicable requirements and the preparation of validation reports.

CELLnTEC advanced cell systems AG

Since 2002 · 11–20 empl.

The core activity of CELLnTEC is the development and manufacture of products and technologies for precision cell culture, particularly cell culture media designed for research and clinical applications. The company offers a range of products, including basic and specialized media, primary cells and complementary reagents required for cell culture and the development of cell therapies.

msd GmbH

Since 2003 · 1–10 empl.

msd GmbH is a research-focused biopharmaceutical company that discovers and develops medicines and vaccines. Its main areas include oncology, vaccines, infectious diseases and cardiometabolic disorders, and the company conducts clinical research and trials.

Alpen Pharma AG

Since 2006 · 101–500 empl.

Alpen Pharma AG is the Swiss representative of a pharmaceutical group that markets, distributes, manufactures and promotes medicines. The group also provides medicine registration services and plans and conducts clinical trials.

SWAN Isotopen AG

Since 2007 · 21–50 empl.

SWAN Isotopen AG operates a radiopharmaceutical production facility and manufactures GMP-compliant radiopharmaceuticals for molecular diagnostics. In collaboration with research groups at the University of Bern, it develops diagnostic agents and radiotherapeutics, and provides transport services for radioactive materials.

Exopharm AG

Since 2017 · 1–10 empl.

Exopharm AG supplies pharmaceutical products, including branded medicines and generics, and related medical accessories and services to regional distributors. Its services include logistics (including GDP-compliant cold chain), regulatory affairs (pre- and post-marketing and market access) and promotional support.

Space Pharmaceuticals AG

Since 2018 · 1–10 empl.

Space Pharmaceuticals AG provides CRDMO services for peptide research, development and manufacturing, including peptide discovery, custom synthesis and GMP peptide production. The company also offers process and analytical development, preclinical/clinical support and a portfolio of generic peptide APIs.